Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Danielle Boyce, Michael Robinson, Jesse M. Cedarbaum, Lisa M. Shank, Christopher J. McDermott & Ruben P. A. van Eijk. (2023) A qualitative evaluation of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R) by the patient community: a web-based cross-sectional survey. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 272-280.
Read now
Read now
Kevin M. Pitt & Jonathan S. Brumberg. (2022) Evaluating person-centered factors associated with brain–computer interface access to a commercial augmentative and alternative communication paradigm. Assistive Technology 34:4, pages 468-477.
Read now
Read now
Jiao Liu, Xiaoyue Luo, Xueping Chen & Huifang Shang. (2020) Serum creatinine levels in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 502-508.
Read now
Read now
Carolyn A. Young, Roger Mills, Ammar Al-Chalabi, Georgina Burke, Siddharthan Chandran, David J Dick, John Ealing, C. Oliver Hanemann, Timothy Harrower, Christopher J. Mcdermott, Tahir Majeed, Ashwin Pinto, Kevin Talbot, Jannette Walsh, Timothy L. Williams & Alan Tennant. (2020) Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:5-6, pages 364-372.
Read now
Read now
. (2018) Theme 9 Clinical trials and trial design. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:sup1, pages 264-281.
Read now
Read now
Koji Takei, Fumihiro Takahashi, Shawn Liu, Kikumi Tsuda & Joseph Palumbo. (2017) Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:sup1, pages 49-54.
Read now
Read now
Articles from other publishers (22)
Cara Donohue, Jennifer L. Chapin, Amber Anderson, Lauren DiBiase, Lauren Tabor Gray, James P. Wymer & Emily K. Plowman. (2023) Sensitivity and specificity of the Amyotrophic Lateral Sclerosis Functional Rating Scale—Revised to detect dysarthria in individuals with amyotrophic lateral sclerosis. Muscle & Nerve 68:3, pages 296-302.
Crossref
Crossref
Reza Boostani, Nahid Olfati, Hosein Shamshiri, Zanireh Salimi, Farzad Fatehi, Seyed Arya Hedjazi, Atefeh Fakharian, Majid Ghasemi, Ali Asghar Okhovat, Keivan Basiri, Bahram Haghi Ashtiani, Behnaz Ansari, Gholam Reza Raissi, Seyed Ahmadreza Khatoonabadi, Payam Sarraf, Sara Movahed, Akram Panahi, Bentolhoda Ziaadini, Mohammad Yazdchi, Jalal Bakhtiyari & Shahriar Nafissi. (2023) Iranian clinical practice guideline for amyotrophic lateral sclerosis. Frontiers in Neurology 14.
Crossref
Crossref
Susan L. Hartmaier, Thomas Rhodes, Suzanne F. Cook, Courtney Schlusser, Chao Chen, Steve Han, Neta Zach, Venkatesha Murthy & Shreya Davé. (2022) Qualitative measures that assess functional disability and quality of life in ALS. Health and Quality of Life Outcomes 20:1.
Crossref
Crossref
Leigh E. Colvin, Zachariah W. Foster, Thor D. Stein, Manisha Thakore‐James, Mohammad Kian Salajegheh, Kendall Carr, Keith R. Spencer, Nazifa Abdul Rauf, Latease Adams, James G. Averill, Sean E. Walker, Ian Robey, Victor E. Alvarez, Bertrand R. Huber, Ann C. McKee, Neil W. Kowall & Christopher B. Brady. (2022)
Utility of the
ALSFRS‐R
for predicting
ALS
and comorbid disease neuropathology: The Veterans Affairs Biorepository Brain Bank
. Muscle & Nerve 66:2, pages 167-174.
Crossref
Crossref
Betts Peters, Brandon Eddy, Deirdre Galvin-McLaughlin, Gail Betz, Barry Oken & Melanie Fried-Oken. (2022) A systematic review of research on augmentative and alternative communication brain-computer interface systems for individuals with disabilities. Frontiers in Human Neuroscience 16.
Crossref
Crossref
Sanjeev Kharel, Rajeev Ojha, Veeramani Preethish‐Kumar & Riwaj Bhagat. (2022) C‐reactive protein levels in patients with amyotrophic lateral sclerosis: A systematic review. Brain and Behavior 12:3.
Crossref
Crossref
Özden O. Dalgıç, Haoran Wu, F. Safa Erenay, Mustafa Y. Sir, Osman Y. Özaltın, Brian A. Crum & Kalyan S. Pasupathy. (2021) Mapping of critical events in disease progression through binary classification: Application to amyotrophic lateral sclerosis. Journal of Biomedical Informatics 123, pages 103895.
Crossref
Crossref
Stanisław Maksymowicz, Paula Kukołowicz, Tomasz Siwek & Agnieszka Rakowska. (2020) Validation of the revised Amyotrophic Lateral Sclerosis Functional Rating Scale in Poland and its reliability in conditions of the medical experiment. Neurological Sciences 42:3, pages 943-949.
Crossref
Crossref
Malin Sixt Börjesson, Lena Hartelius & Katja Laakso. (2021) Communicative Participation in People with Amyotrophic Lateral Sclerosis. Folia Phoniatrica et Logopaedica 73:2, pages 101-108.
Crossref
Crossref
E. Srinivasan & R. Rajasekaran. (2020) A Systematic and Comprehensive Review on Disease-Causing Genes in Amyotrophic Lateral Sclerosis. Journal of Molecular Neuroscience 70:11, pages 1742-1770.
Crossref
Crossref
Ahmad R. Abuzinadah, Aysha A. AlShareef, Abdullah AlKutbi, Ahmed K. Bamaga, Ali Alshehri, Hussein Algahtani, Edward Cupler & Mohammed H. Alanazy. (2020) Amyotrophic lateral sclerosis care in Saudi Arabia: A survey of providers’ perceptions. Brain and Behavior 10:10.
Crossref
Crossref
Jennifer L. Chapin, Lauren Tabor Gray, Terrie Vasilopoulos, Amber Anderson, Lauren DiBiase, Justine Dallal York, Raele Robison, James Wymer & Emily K. Plowman. (2020) Diagnostic utility of the amyotrophic lateral sclerosis Functional Rating Scale—Revised to detect pharyngeal dysphagia in individuals with amyotrophic lateral sclerosis. PLOS ONE 15:8, pages e0236804.
Crossref
Crossref
Jin-Mo Park, Sun-Young Kim, Donghwi Park & Jin-Sung Park. (2019) Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients. Neurological Sciences 41:1, pages 119-123.
Crossref
Crossref
Jue Wang & Sheng Luo. (2018) Joint modeling of multiple repeated measures and survival data using multidimensional latent trait linear mixed model. Statistical Methods in Medical Research 28:10-11, pages 3392-3403.
Crossref
Crossref
Michael Lee & Alana McCambridge. (2018) Clinimetrics: Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-R). Journal of Physiotherapy 64:4, pages 269-270.
Crossref
Crossref
Dongwoo Chae & Kyungsoo Park. (2018) An item response theory based integrated model of headache, nausea, photophobia, and phonophobia in migraine patients. Journal of Pharmacokinetics and Pharmacodynamics 45:5, pages 721-731.
Crossref
Crossref
Sinikka Tarvonen-Schröder, Anne Kaljonen & Katri Laimi. (2018) Disability in amyotrophic lateral sclerosis compared with traumatic brain injury using the World Health Organization Disability Assessment Schedule 2.0 and the International Classification of Functioning minimal generic set. International Journal of Rehabilitation Research 41:3, pages 224-229.
Crossref
Crossref
Ruben P.A. van Eijk, Stavros Nikolakopoulos, Toby A. Ferguson, Dawei Liu, Marinus J.C. Eijkemans & Leonard H. van den Berg. (2018) Increasing the efficiency of clinical trials in neurodegenerative disorders using group sequential trial designs. Journal of Clinical Epidemiology 98, pages 80-88.
Crossref
Crossref
Ruben P A van Eijk, Marinus J C Eijkemans, Toby A Ferguson, Stavros Nikolakopoulos, Jan H Veldink & Leonard H van den Berg. (2018) Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials. Journal of Neurology, Neurosurgery & Psychiatry 89:2, pages 156-161.
Crossref
Crossref
Patricia L. Andres, Margaret (Peggy) Allred, Helen E. Stephens, Mary Proffitt Bunnell, Catherine Siener, Eric A. Macklin, Travis Haines, Robert A. English, Katherine A. Fetterman, Edward J. Kasarskis, Julaine Florence, Zachary Simmons & Merit E. Cudkowicz. (2017) Fixed dynamometry is more sensitive than vital capacity or ALS rating scale. Muscle & Nerve 56:4, pages 710-715.
Crossref
Crossref
Jue WangSheng Luo. (2017) Multidimensional latent trait linear mixed model: an application in clinical studies with multivariate longitudinal outcomes. Statistics in Medicine 36:20, pages 3244-3256.
Crossref
Crossref
Leonhard A. Bakker, Carin D. Schröder, Michael A. van Es, Paul Westers, Johanna M. A. Visser-Meily & Leonard H. van den Berg. (2017) Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model. Journal of Neurology 264:7, pages 1413-1420.
Crossref
Crossref